Miller MC

No ORCID on file · 4 papers in corpus · active 2009-2012

Study types

  • other 1

Condition tags

  • endometriosis 1
other 2012
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2011.12.029

OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer. This study measured the HE4 and CA125 levels in women with benign gynecological disorders. STUDY DESIGN: Sera were obtained from women prior to surger…

2012
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2011.12.028

ObjectiveThe purpose of this study was to establish normal ranges for human epididymis protein 4 (HE4) serum levels in healthy women.Study designHE4 levels were measured in healthy women and analyzed by age, menopausal status, and pregnancy…

2011
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Obstetrics and gynecology ·doi:10.1097/aog.0b013e318224fce2

ObjectiveIt is often difficult to distinguish a benign pelvic mass from a malignancy and tools to help referring physician are needed. The purpose of this study was to validate the Risk of Ovarian Malignancy Algorithm in women presenting wi…

2009
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.08.031

IntroductionPatients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk for…